1. Home
  2. Tags
  3. Rare Disease Drug Development

Latest Rare Disease Drug Development News

Page 1 of 1
Neuren Secures FDA Type C Meeting to Finalise Phase 3 Trial Design for Rare Syndrome

Neuren Secures FDA Type C Meeting to Finalise Phase 3 Trial Design for Rare Syndrome

Neuren Pharmaceuticals has secured a pivotal FDA Type C Meeting to discuss primary efficacy endpoints for its Phase 3 trial of NNZ-2591 targeting Phelan-McDermid syndrome, advancing its rare disease drug development.
Victor Sage
Victor Sage
7 Feb 2025